Back to search
Pancreas Adenocarcinoma (MSI-H)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pancreas Adenocarcinoma (MSI-H) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pancreas Adenocarcinoma (MSI-H) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A phase II study combining pembrolizumab with olaparib in metastatic pancreatic adenocarcinoma patients with high tumour mutation burden
This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of…
Pancreatic cancer exhibits significant heterogeneity, which poses a major challenge in selecting the best treatment for patients from the very beginning of care…
INDP-D101 is a Phase 1/2, open-label, multi-center, dose escalation and expansion study evaluating the safety, tolerability and clinical activity of Decoy20 as…